Quick Answer
Nu-Med Plus, Inc. reported Stockholders Equity of -$215.1 thousand for fiscal year 2024.
Nu-Med Plus, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$215.1K | -46.6% |
| 2023 | -$146.8K | -132.8% |
| 2022 | -$63.0K | +52.4% |
| 2021 | -$132.4K | -128.3% |
| 2020 | $467.7K | +226.3% |
| 2019 | -$370.4K | -863.4% |
| 2018 | $48.5K | -28.9% |
| 2017 | $68.2K | +101.5% |
| 2016 | -$4.44M | +70.8% |
| 2015 | -$15.22M | -114.0% |
| 2014 | -$7.11M | -5620.0% |
| 2013 | -$124.3K | -169.8% |
| 2012 | -$46.1K | -15574.8% |
| 2011 | -$294.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$258.7K | -26.5% | -4.9% |
| June 30, 2025 | -$246.7K | -32.7% | -5.0% |
| March 31, 2025 | -$235.0K | -39.4% | -9.3% |
| December 31, 2024 | -$215.1K | -46.6% | -5.2% |
| September 30, 2024 | -$204.5K | -55.0% | -10.0% |
| June 30, 2024 | -$185.9K | -60.9% | -10.3% |
| March 31, 2024 | -$168.6K | -84.8% | -14.9% |
| December 31, 2023 | -$146.8K | -132.8% | -11.2% |
- Nu-Med Plus, Inc. showed a decrease of -46.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2024 period, Nu-Med Plus, Inc.’s stockholders equity has declined by 73061.9% (from -$294.00 to -$215.1 thousand).
- The most recent figure is from Nu-Med Plus, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: